Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in CERS — Cerus Corp

CIK 1164508 BOSTON, MA
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$448,894
-$78,385 QoQ
Shares Held
153,731
-39.9% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 186 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $6,436,102,900 across 46 Medical Devices names. CERS ranks #44 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 3,282,207 $1,033,370,051
2 MDT
Medtronic plc
 12,892,710 $1,008,596,703
3 BSX
Boston Scientific Corp
 23,293,913 $994,184,206
4 ABT
Abbott Laboratories
 10,897,178 $988,809,931
5 EW
Edwards Lifesciences Corp
 5,677,344 $513,572,538
6 DXCM
Dexcom Inc
 6,873,273 $462,914,936
7 PEN
Penumbra Inc
 834,903 $263,620,622
8 STE
STERIS plc
 1,217,864 $256,445,622

All Filings in CERS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $448,894 153,731
2025-12-31 $527,279 255,961